<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">


Is dexamethasone a major Covid breakthrough?

17 June 2020

6:23 AM

17 June 2020

6:23 AM

Just how a big a deal is today’s announcement that the steroid anti-inflammatory drug Dexamethasone has been shown to be effective at lowering the death toll of Covid-19 patients?

At first sight, this is a modest breakthrough. The drug was shown to reduce the death rate among patients on ventilators by a third and among those on oxygen by a fifth.

Already a subscriber? Log in

Subscribe for just $2 a week

Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk

Unlock this article



Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in